Ozempic-maker accuses rival of false advertising
Novo Nordisk has launched legal action accusing Eli Lilly of creating "misleading" ads, a claim its rival denies.
Novo Nordisk has launched legal action accusing Eli Lilly of creating "misleading" ads, a claim its rival denies. This story matters for General News readers tracking baha. Reported by bbc.co.uk. Read the full original at the source link below.
Originally reported by bbc.co.uk. BahaNews curates and briefs the general news stories that matter. Our editorial policy →